McWhinney C D, Hunt R A, Conrad K M, Dostal D E, Baker K M
Sigfried and Janet Weis Center for Research, Geisinger Clinic, 100 N. Academy Avenue, Danville, Pennsylvania, 17822, USA.
J Mol Cell Cardiol. 1997 Sep;29(9):2513-24. doi: 10.1006/jmcc.1997.0489.
The octapeptide, angiotensin II, has a modulatory role on cardiac cellular growth associated with hypertension and in compensatory remodeling following myocardial infarction. The molecular signal transduction pathways that participate in these and other cellular actions in response to angiotensin II are presently being elucidated. The signal transducers and activators of transcription (STAT) pathway directly links cytokine and growth factor receptors with transcriptional activity. We provide evidence that the G protein-linked, angiotensin II, AT1-receptor couples to activation of the STAT pathway in neonatal rat cardiac myocytes. Angiotensin II induces primarily sis-inducing factor (SIF) B and to a lesser extent SIF-C and SIF-A. The EC50 of this response was 40 nM and Stat1 and Stat3 proteins were identified as components of the SIF complexes. Stat1 and Stat3 were tyrosine phosphorylated five-fold and three-fold, respectively, over control levels following angiotensin II treatment of cardiac myocytes. Phosphorylation of Stat1 and Stat3 proteins was rapid (5 min) and sustained (60 min). Jak2 was also tyrosine phosphorylated eight-fold by angiotensin II treatment, and phosphorylated Stat1 and Stat3 proteins co-immunoprecipitated with activated Jak2 kinase. Selective inhibition of Jak2 kinase with AG-490 blocked formation of angiotensin II induced SIF complexes, suggesting that Jak2 kinase is required for cardiomyocyte SIF induction. In addition, Jak2, Stat1 and Stat3 proteins co-immunoprecipitated with the AT1-receptor. These are the first data to demonstrate coupling of a G-protein coupled receptor, AT1, to the JAK-STAT pathway in primary cultured cardiac myocytes and suggest that this pathway may be involved in transcriptional regulation by angiotensin II.
八肽血管紧张素II对与高血压相关的心脏细胞生长以及心肌梗死后的代偿性重塑具有调节作用。目前正在阐明参与这些以及其他对血管紧张素II产生反应的细胞作用的分子信号转导途径。信号转导子和转录激活子(STAT)途径直接将细胞因子和生长因子受体与转录活性联系起来。我们提供的证据表明,G蛋白偶联的血管紧张素II AT1受体与新生大鼠心肌细胞中STAT途径的激活相关联。血管紧张素II主要诱导sis诱导因子(SIF)B,在较小程度上诱导SIF-C和SIF-A。这种反应的半数有效浓度(EC50)为40 nM,Stat1和Stat3蛋白被鉴定为SIF复合物的组成成分。在血管紧张素II处理心肌细胞后,Stat1和Stat3的酪氨酸磷酸化水平分别比对照水平高5倍和3倍。Stat1和Stat3蛋白的磷酸化迅速(5分钟)且持续(60分钟)。血管紧张素II处理还使Jak2的酪氨酸磷酸化水平提高了8倍,并且磷酸化的Stat1和Stat3蛋白与活化的Jak2激酶共免疫沉淀。用AG-490选择性抑制Jak2激酶可阻断血管紧张素II诱导的SIF复合物的形成,这表明Jak2激酶是心肌细胞SIF诱导所必需的。此外,Jak2、Stat1和Stat3蛋白与AT1受体共免疫沉淀。这些是首次证明在原代培养的心肌细胞中G蛋白偶联受体AT1与JAK-STAT途径相关联的数据,并表明该途径可能参与血管紧张素II的转录调控。